These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 9103733)

  • 1. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review.
    Abramowitz JS
    J Consult Clin Psychol; 1997 Feb; 65(1):44-52. PubMed ID: 9103733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study.
    Feng B; Zhang ZJ; Zhu RM; Yuan GZ; Luo LY; McAlonan GM; Xu FZ; Chen J; Liu LY; Lv YY; Wong HK; Zhang Y; Zhu LX
    J Psychiatr Res; 2016 Sep; 80():30-37. PubMed ID: 27281260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure with response prevention and serotonergic antidepressants in the treatment of obsessive compulsive disorder: a review and implications for interdisciplinary treatment.
    Abel JL
    Behav Res Ther; 1993 Jun; 31(5):463-78. PubMed ID: 8101439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic therapy of obsessive compulsive disorder.
    DeVeaugh-Geiss J
    Adv Pharmacol; 1994; 30():35-52. PubMed ID: 7833296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.
    Hembree EA; Riggs DS; Kozak MJ; Franklin ME; Foa EB
    CNS Spectr; 2003 May; 8(5):363-71, 381. PubMed ID: 12766692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
    Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
    Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B; Nestadt G; Allen A; Hollander E
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in the pharmacological treatment of obsessive-compulsive disorder.
    Math SB; Janardhan Reddy YC
    Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].
    Baving L; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):35-44. PubMed ID: 10746297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case study: successful medication withdrawal using cognitive-behavioral therapy for a preadolescent with OCD.
    Sallinen BJ; Nangle DW; O'Grady AC
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1441-4. PubMed ID: 15502604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.
    Fineberg NA; Reghunandanan S; Simpson HB; Phillips KA; Richter MA; Matthews K; Stein DJ; Sareen J; Brown A; Sookman D;
    Psychiatry Res; 2015 May; 227(1):114-25. PubMed ID: 25681005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative effectiveness of treatments for obsessive-compulsive disorder.
    Greist JH
    Bull Menninger Clin; 1998; 62(4 Suppl A):A65-81. PubMed ID: 9810778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive disorder: unearthing a hidden problem.
    El-Sayegh S; Bea S; Agelopoulos A
    Cleve Clin J Med; 2003 Oct; 70(10):824-5, 829-30, 832-3, passim. PubMed ID: 14621230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
    Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
    J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obsessive-Compulsive Disorders.
    Mathews C
    Continuum (Minneap Minn); 2021 Dec; 27(6):1764-1784. PubMed ID: 34881735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis.
    Sánchez-Meca J; Rosa-Alcázar AI; Iniesta-Sepúlveda M; Rosa-Alcázar A
    J Anxiety Disord; 2014 Jan; 28(1):31-44. PubMed ID: 24334214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenting treatment of obsessive-compulsive disorder with Antonovsky's sense of coherence theory.
    Joachim B; Lyon DD; Farrell SP
    Perspect Psychiatr Care; 2003; 39(4):163-8. PubMed ID: 14737822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.